LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Emergent BioSolutions Inc

Emergent BioSolutions Inc

Suletud

Sektor Tervishoid

7.46 -2.23

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.45

Max

7.6

Põhinäitajad
By Trading Economics
Müük	6.1M 277M
Aktsiakasum	-0.77
Töötajad	1,600

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+59.57 upside

Turustatistika
By TradingEconomics
Turukapital	1.1M 121M
Eelmine avamishind	9.69
Eelmine sulgemishind	7.46

Uudiste sentiment

By Acuity

88%

12%

333 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

7.39 / 8.91 Toetus ja vastupanu

Emergent BioSolutions Inc Graafik

Seotud uudised

12. märts 2024, 15:10 UTC

Suurimad hinnamuutused turgudel

Emergent BioSolutions Shares Drop on S&P Downgrade

Võrdlus sarnastega

Hinnamuutus

Emergent BioSolutions Inc Prognoos

Hinnasiht

By TipRanks

59.57% tõus

12 kuu keskmine prognoos

Keskmine 12 USD 59.57%

Kõrge 16 USD

Madal 8 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Emergent BioSolutions Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Emergent BioSolutions Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

7.39 / 8.91Toetus ja vastupanu

All events are bearish.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

333 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Emergent BioSolutions Inc

Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.